Roswell Park Comprehensive Cancer Center: Chemotherapy Should Be Considered for Patients With Small ERBB2-Positive Breast Cancers
April 18, 2020
April 18, 2020
BUFFALO, New York, April 18 -- The Roswell Park Comprehensive Cancer Center issued the following news release:
A sizable subset of people with breast cancer, those who have small tumors and a favorable hormone-receptor profile but one notable risk factor -- they test positive for a protein associated with more aggressive tumor growth -- often are not offered chemotherapy as part of their recommended treatment strategy. But a new analysis led by physicians at Roswell Park Comprehensi . . .
A sizable subset of people with breast cancer, those who have small tumors and a favorable hormone-receptor profile but one notable risk factor -- they test positive for a protein associated with more aggressive tumor growth -- often are not offered chemotherapy as part of their recommended treatment strategy. But a new analysis led by physicians at Roswell Park Comprehensi . . .